master's thesis
Clinical immunotherapy of tumors with monoclonal antibodies against checkpoint molecules on T-lymphocytes

Marko Mežnarić (2018)
University of Zagreb
School of Medicine
Chair of Clinical Oncology
Cite this document...

Mežnarić, M. (2018). Klinička imunoterapija tumora s antitijelima protiv inhibicijskih receptora T-limfocita (Master's thesis). Retrieved from https://urn.nsk.hr/urn:nbn:hr:105:033070

Mežnarić, Marko. "Klinička imunoterapija tumora s antitijelima protiv inhibicijskih receptora T-limfocita." Master's thesis, University of Zagreb, School of Medicine, 2018. https://urn.nsk.hr/urn:nbn:hr:105:033070

Mežnarić, Marko. "Klinička imunoterapija tumora s antitijelima protiv inhibicijskih receptora T-limfocita." Master's thesis, University of Zagreb, School of Medicine, 2018. https://urn.nsk.hr/urn:nbn:hr:105:033070

Mežnarić, M. (2018). 'Klinička imunoterapija tumora s antitijelima protiv inhibicijskih receptora T-limfocita', Master's thesis, University of Zagreb, School of Medicine, accessed 20 March 2019, https://urn.nsk.hr/urn:nbn:hr:105:033070

Mežnarić M. Klinička imunoterapija tumora s antitijelima protiv inhibicijskih receptora T-limfocita [Master's thesis]. Zagreb: University of Zagreb, School of Medicine; 2018 [cited 2019 March 20] Available at: https://urn.nsk.hr/urn:nbn:hr:105:033070

M. Mežnarić, "Klinička imunoterapija tumora s antitijelima protiv inhibicijskih receptora T-limfocita", Master's thesis, University of Zagreb, School of Medicine, Zagreb, 2018. Available at: https://urn.nsk.hr/urn:nbn:hr:105:033070